4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-18-001245
Options or other derivatives
- Chief Scientific Officer acquired 47,000 shares (grant or award)
From the SEC's structured data for this filing
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-18-001245
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…